Anesthetic management of patients with ischemic heart disease, outline the hemodynamic goals of induction and maintenance of general anesthesia in patients with ischemic heart disease. For MD Anaesthesia exam

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have all the core textbook content needed. Let me compile the comprehensive MD Anesthesia exam answer.

Anesthetic Management of Patients with Ischemic Heart Disease

Hemodynamic Goals of Induction and Maintenance of General Anesthesia


Core Pathophysiological Principle

The single overriding objective in managing patients with ischemic heart disease (IHD) is maintaining a favorable myocardial oxygen supply-demand relationship. Every hemodynamic goal derives from this principle.
Myocardial ischemia occurs when oxygen demand exceeds supply. Unlike other tissues that can compensate for reduced flow by increasing oxygen extraction, the myocardium already extracts 65% of arterial oxygen at rest (coronary sinus O₂ saturation ~30%). Therefore, any increase in demand must be met by increased coronary blood flow - which is impaired in IHD.

Determinants of Myocardial O₂ Supply and Demand

SupplyDemand
Heart rate (diastolic filling time)Heart rate
Coronary perfusion pressure (Aortic DBP - LVEDP)Wall tension (Preload - ventricular radius; Afterload)
Arterial O₂ content (PaO₂, Hb)Contractility (inotropy)
Coronary vessel diameterBasal metabolic requirements
Key point: Heart rate and LVEDP appear on both sides - they are the most critical determinants to control perioperatively.
Left coronary perfusion pressure = Aortic Diastolic Pressure - LVEDP
  • The left ventricle is perfused almost entirely during diastole
  • Tachycardia disproportionately reduces diastolic time, simultaneously increasing demand and reducing supply - the most dangerous combination in IHD
  • The right ventricle is perfused during both systole and diastole

HEMODYNAMIC GOALS

1. Heart Rate - THE MOST CRITICAL PARAMETER

Target: 50-70 bpm (normal sinus rhythm, avoid tachycardia)
  • Tachycardia is the most common precipitant of perioperative ischemia; it increases demand and reduces supply simultaneously
  • Disproportionate shortening of diastolic time at higher heart rates (diastolic time falls non-linearly with HR) directly limits coronary perfusion
  • Bradycardia <45 bpm should also be avoided as it reduces cardiac output
  • The most common hemodynamic abnormalities seen during ischemic episodes are hypertension and tachycardia - they are almost always the cause (not the result) of ischemia
How to maintain:
  • Adequate depth of anesthesia before laryngoscopy
  • Opioid preloading (fentanyl 2-5 mcg/kg before intubation) to blunt laryngoscopy response
  • Beta-blockers (esmolol 0.5-1 mg/kg IV) to treat intraoperative tachycardia
  • Volatile agents (all have rate-lowering tendency at adequate MAC)
  • Avoid anticholinergic tachycardia; if needed for bradycardia, use glycopyrrolate (less tachycardia than atropine)

2. Blood Pressure - Maintain in a Narrow Range

Target: Within ±20% of baseline; avoid both hypertension and hypotension

A. Hypertension

  • Increases afterload → increases wall tension → increases O₂ demand
  • Hypertension during laryngoscopy/intubation is one of the most dangerous moments
  • Down-sloping/horizontal ST depression almost always accompanies severe hypertensive responses in IHD patients
  • Management: adequate depth (volatile agent titration), iv fentanyl, β-blockers, nitroglycerin, nicardipine

B. Hypotension

  • Reduces coronary perfusion pressure (Aortic DBP - LVEDP)
  • Hypotension is a late and ominous manifestation of progressive ventricular dysfunction
  • Higher diastolic pressures are preferable in patients with high-grade coronary occlusions
  • The endocardium is most vulnerable to ischemia during hypotension (highest intramural pressures during systole)
  • Management: vasopressors (phenylephrine preferred - pure α-agonist, does not increase HR; norepinephrine if cardiac output low); treat cause (hypovolemia, vasodilation from anesthetics, myocardial depression)

3. Preload (LVEDP / Filling Pressures)

Target: Avoid extremes - maintain "euvolemia"
  • Excessive preload (fluid overload): Increases LVEDP → reduces coronary perfusion pressure (supply falls) AND increases ventricular wall tension (demand rises) - a double jeopardy
  • Elevated LVEDP specifically reduces subendocardial perfusion
  • Hypovolemia: Reduces preload → reduces cardiac output → hypotension → reduces coronary perfusion
  • Optimal filling: guided by clinical assessment, arterial waveform variation, or TEE (LV chamber size)
  • PAC-measured PCWP rises abruptly with ischemia (though PAC rarely used now)

4. Contractility

Target: Avoid excessive myocardial depression or unnecessary inotropic stimulation
  • Increased contractility = increased O₂ demand
  • Excessive anesthetic-induced depression → low CO → hypotension → reduced perfusion
  • Most volatile agents are mildly negatively inotropic - this is acceptable and even beneficial at moderate doses (reduce demand, reduce preload/afterload)
  • Volatile agents also exert anesthetic preconditioning - activate ATP-sensitive K⁺ channels, reduce reperfusion injury, help "stunned" myocardium recover
  • Avoid catecholamine surges (laryngoscopy, surgical stimulation) - they massively increase contractility and HR simultaneously

5. Systemic Vascular Resistance (Afterload)

Target: Avoid marked elevation or reduction
  • High SVR → increased wall tension → increased O₂ demand
  • Low SVR → hypotension → reduced coronary perfusion pressure
  • The goal is stable SVR within normal limits

6. Arterial Oxygen Content (CaO₂)

Target: SpO₂ >99%, Hb ≥7-8 g/dL
  • Maintain adequate oxygenation and ventilation throughout
  • Anemia → compensatory tachycardia → worsens supply-demand balance
  • Most clinicians are reluctant to allow Hb <7 g/dL in CAD patients; transfusion decision is individualized
  • Hypoventilation with resulting hypoxia and hypercarbia (both cause sympathetic stimulation and tachycardia) must be avoided

INDUCTION - SPECIFIC GOALS AND STRATEGIES

The Critical Period: Induction and Laryngoscopy

Induction and intubation represent the highest-risk hemodynamic period because:
  1. Anesthetic agents cause vasodilation/myocardial depression → risk of hypotension
  2. Laryngoscopy causes intense sympathetic stimulus → tachycardia and hypertension
The hemodynamic "ideal" for induction:
ParameterGoal
HR60-70 bpm, no tachycardia >90 bpm
SBP±20% of baseline, avoid >160 mmHg or sudden fall
DBPMaintain (ensures coronary perfusion)
MAP≥60-70 mmHg
No rhythm changeSinus rhythm maintained

Induction Agents

  • Propofol: Most commonly used; causes vasodilation and mild myocardial depression - titrate slowly to avoid sudden hypotension; use with opioid preloading
  • Etomidate: Hemodynamically most stable (minimal CVS effects) - preferred when LV function is compromised; causes minimal change in HR, BP, and SVR; however does not blunt laryngoscopy response
  • Ketamine: Generally avoided in IHD - sympathomimetic properties increase HR, BP, and O₂ demand; occasionally used when hemodynamics are very compromised
  • Thiopental: Historically used, causes vasodilation and mild myocardial depression

Blunting Laryngoscopy Response

This is a key intraoperative goal. Options include:
  1. Opioid preloading - fentanyl 2-5 mcg/kg, remifentanil infusion
  2. Lignocaine IV - 1.5 mg/kg given 90 seconds before intubation
  3. Beta-blockers - esmolol 1-2 mg/kg bolus before laryngoscopy
  4. Topical laryngeal analgesia - 4% lignocaine spray
  5. Adequate depth - deep enough volatile anesthetic or propofol before laryngoscopy
  6. Keep laryngoscopy brief - <15 seconds; use video laryngoscope

MAINTENANCE - SPECIFIC GOALS

Choice of Anesthetic Agents

Volatile agents (isoflurane, sevoflurane, desflurane) are preferred:
  • All are coronary vasodilators
  • Reduce myocardial O₂ requirements
  • Provide anesthetic preconditioning (cardioprotection via KATP channels)
  • Reduce preload and afterload at moderate doses
  • Caveat: Desflurane causes sympathetic stimulation during rapid increases in concentration → avoid rapid up-titration in IHD
TIVA (propofol-based) is an acceptable alternative:
  • ACC/AHA Class IIa recommendation: either volatile or TIVA is reasonable (LOE: A)
  • Propofol reduces preload and afterload but lacks preconditioning benefit
Opioids:
  • High-dose opioid techniques provide excellent hemodynamic stability
  • Fentanyl, sufentanil, remifentanil - blunt sympathetic responses, minimal direct cardiac depression
  • Remifentanil infusion is particularly useful for moment-to-moment titration
Neuromuscular Blockade:
  • Vecuronium or rocuronium preferred (minimal cardiovascular effects)
  • Avoid pancuronium (vagolytic - causes tachycardia)
  • Avoid succinylcholine as primary agent if not needed urgently (fasciculations → transient increases in IOP and oxygen demand)

Maintaining Hemodynamic Stability During Surgery

Treat tachycardia promptly:
  • Increase depth of anesthesia
  • Esmolol (short-acting β-blocker) or metoprolol
  • Address pain/light anesthesia
  • Ensure adequate analgesia
Treat hypertension:
  • Deepen anesthesia, increase volatile agent
  • Nicardipine, labetalol, or GTN infusion
  • Ensure adequate opioid analgesia
Treat hypotension:
  • Reduce anesthetic depth
  • IV fluid bolus if hypovolemic
  • Phenylephrine (if BP low, HR normal/high)
  • Ephedrine (if BP low, HR low)
  • Check ECG for new ischemia immediately

Temperature

  • Maintain normothermia - hypothermia → shivering post-op → massive increase in O₂ demand; ACC/AHA Class IIb recommendation

MONITORING REQUIREMENTS

MonitorRationale
ECG - Leads II and V5 simultaneouslyII: inferior ischemia + arrhythmias; V5: anterior wall (most sensitive single lead)
Invasive arterial BPContinuous beat-to-beat BP, access for ABG
SpO₂ and capnographyContinuous oxygenation, ventilation
TemperatureNormothermia
Urine outputRenal perfusion as surrogate for CO
TEE (if available)Earlier and more sensitive than ECG for ischemia detection (new RWMA); also assesses volume status
Central venous accessMajor procedures, vasoactive drug delivery
ECG lead sensitivity for ischemia detection: V5 > V4 > II > V2 > V3
Ischemia on ECG: T-wave inversion (earliest) → ST depression (horizontal or down-sloping >1mm) → ST elevation (severe/transmural ischemia or vasospasm)
TEE advantage: New regional wall motion abnormalities (RWMA) develop before ECG changes when coronary flow is gradually reduced - more sensitive early indicator.

SUMMARY TABLE: Hemodynamic Goals in IHD

ParameterTargetRationale
Heart Rate50-70 bpmTachycardia = #1 cause of ischemia; ↑HR → ↑demand + ↓supply
Systolic BP±20% of baselineHypertension ↑wall tension (demand); hypotension ↓CPP (supply)
Diastolic BPMaintain or slightly elevatedCPP = Aortic DBP - LVEDP; DBP critical for LV perfusion
MAP≥65-70 mmHgMinimum for coronary autoregulation
LVEDP (preload)EuvolemiaHigh LVEDP: ↓CPP + ↑wall tension; low: ↓CO + hypotension
ContractilityNormalExcessive inotropic state ↑demand
SVR (afterload)Normal↑SVR → ↑wall tension; ↓SVR → hypotension
SpO₂>99%CaO₂ is a supply determinant
Hemoglobin≥7-8 g/dLAnemia → compensatory tachycardia
TemperatureNormothermiaHypothermia → shivering → massive ↑demand

KEY EXAM POINTS TO REMEMBER

  1. Tachycardia is the enemy - it simultaneously increases demand and reduces supply by shortening diastole
  2. Coronary perfusion pressure = Aortic DBP - LVEDP - both sides of this equation matter
  3. The myocardium cannot increase oxygen extraction (already near-maximal at rest) - supply must match demand
  4. Volatile agents are cardioprotective via preconditioning (KATP channel activation) - this is a pharmacological advantage over TIVA
  5. Hypotension is a late sign of ventricular dysfunction - by the time BP falls due to ischemia, significant myocardium is already compromised; the goal is to prevent this from happening
  6. Induction and laryngoscopy are the highest-risk periods - use opioid preloading, adequate depth, and short laryngoscopy time
  7. Etomidate is the hemodynamically most stable induction agent - preferred in compromised LV function
  8. Pancuronium is contraindicated - vagolytic tachycardia
  9. TEE > ECG for early ischemia detection (RWMA precede ST changes)
  10. ACC/AHA: Either volatile or TIVA is acceptable (Class IIa, LOE A); prophylactic intraoperative nitroglycerin is not recommended (Class III: No Benefit)

Sources: Morgan and Mikhail's Clinical Anesthesiology, 7e - Chapters 20 (Cardiovascular Physiology), 21 (Anesthesia for Patients with Cardiovascular Disease); ACC/AHA 2014 Guidelines on Perioperative Cardiovascular Evaluation and Management

Goldmans risk index for md Anaesthesia exam short note

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The textbooks reference Goldman but don't reproduce the full original scoring table with point values (it was published in 1977 NEJM). I have enough context from multiple textbooks plus my established knowledge of this classic index to write a comprehensive, accurate short note for MD Anaesthesia exam. Let me compile it now.

Goldman's Cardiac Risk Index (CRI)

Short Note for MD Anaesthesia Exam


Introduction

Goldman's Multifactorial Cardiac Risk Index was introduced by Lee Goldman et al. in 1977 (N Engl J Med. 1977;297:845-850). It was the first validated, quantitative, multifactorial scoring system to predict perioperative cardiac complications in patients undergoing non-cardiac surgery. It had a landmark impact on anaesthetic practice by allowing objective preoperative risk stratification.
Study population: 1,001 consecutive patients aged >40 years undergoing non-cardiac surgery under general anaesthesia at Massachusetts General Hospital.
Primary objective: To identify independent preoperative predictors of life-threatening cardiac complications and cardiac death.

The Nine Risk Factors and Their Point Values

Risk FactorPoints
History
Age >70 years5
Myocardial infarction in the preceding 6 months10
Physical Examination
S3 gallop or raised JVP (signs of congestive cardiac failure)11
Significant aortic valvular stenosis3
ECG
Rhythm other than sinus OR premature atrial contractions on preoperative ECG7
>5 PVCs/minute at any time preoperatively7
General Status
Poor general medical status: PaO₂ <60 or PaCO₂ >50 mmHg, K⁺ <3.0 or HCO₃ <20 mEq/L, urea >50 or creatinine >3 mg/dL, abnormal SGOT, signs of chronic liver disease, or patient bedridden from non-cardiac causes3
Operation
Intraperitoneal, intrathoracic, or aortic surgery3
Emergency operation4
TOTAL53 points
Memory aid: "MI, S3, ECG, Age, Aortic stenosis, Poor status, Big surgery, Emergency" Point values (high to low): S3/JVP (11) > Recent MI (10) > PAC/non-sinus rhythm (7) = PVCs (7) > Age >70 (5) > Emergency op (4) > Aortic stenosis (3) = Big surgery (3) = Poor status (3)

Risk Classification and Cardiac Event Rates

ClassPointsLife-threatening Cardiac ComplicationsCardiac Death
Class I0-50.7%0.2%
Class II6-125%2%
Class III13-2511%2%
Class IV≥2622%56%
  • Class I and II = Low risk - proceed with surgery with standard precautions
  • Class III = Intermediate risk - consider optimization and enhanced monitoring
  • Class IV = High risk - surgery only if absolutely necessary; aggressive optimization; ICU care

Key Observations from the Original Study

  1. Congestive cardiac failure (S3 gallop/raised JVP) carried the highest point value (11) - reflecting the importance of ventricular dysfunction as a risk determinant
  2. Recent MI (<6 months) was the second highest risk factor (10 points). This gave rise to the classic teaching to defer elective surgery for 6 months following MI (now revised downward to 30-60 days with modern revascularization)
  3. Arrhythmias - non-sinus rhythm and frequent PVCs were independent risk factors even without structural disease
  4. Hypertension alone was NOT found to be an independent predictor of perioperative cardiac risk in this study (a surprising and controversial finding at the time)
  5. Type of surgery mattered: major abdominal, thoracic, and aortic operations were higher risk than peripheral procedures

Limitations of the Original Goldman Index

  1. Single-centre study - Massachusetts General Hospital; may not be generalizable
  2. Small sample size (1,001 patients) with relatively few outcome events
  3. Dated - does not include modern risk factors such as diabetes, renal insufficiency, or cerebrovascular disease
  4. Does not account for functional capacity (METs) - a powerful predictor now incorporated in modern guidelines
  5. Does not include type of anaesthesia or quality of intraoperative management
  6. 6-month MI rule has been revised - with modern PCI, elective surgery may be considered at 30-60 days post-MI with appropriate precautions
  7. Aortic and vascular surgery population was poorly represented - performs less well in vascular patients
  8. No provision for echocardiographic or stress testing data

Subsequent Modifications and Evolution

Detsky Modified Cardiac Risk Index (1986)

  • Modified Goldman's index to incorporate unstable angina (class III/IV), pulmonary oedema, and suspected critical aortic stenosis
  • Applied as a pretest probability combined with a nomogram based on surgery type
  • Was the preferred index in American College of Physicians guidelines

Revised Cardiac Risk Index - RCRI (Lee et al., 1999) - THE CURRENT STANDARD

The RCRI replaced Goldman's index in modern practice. It uses 6 equally weighted risk factors (1 point each):
RCRI Factor
1. High-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular)
2. History of ischaemic heart disease
3. History of congestive heart failure
4. History of cerebrovascular disease
5. Insulin-dependent diabetes mellitus
6. Serum creatinine >2.0 mg/dL (preoperative)
RCRI Risk of Major Cardiac Complications:
  • Score 0: ~0.4%
  • Score 1: ~1%
  • Score 2: ~2.5%
  • Score ≥3: ~5-11%

ACS-NSQIP / MICA Calculator (2011, Gupta et al.)

  • Uses 5 variables: type of surgery, dependent functional status, abnormal creatinine, ASA class, and age
  • Better discrimination than RCRI, especially for vascular surgery
  • Provides numerical probability (%) rather than class

Historical Significance and Exam Points

  1. First multifactorial index - moved preoperative assessment from subjective impression to objective scoring
  2. S3 gallop/JVP = highest-weighted single sign (11 points) - reflects overt CCF
  3. Recent MI (within 6 months) = 10 points - led to "6-month rule" (now replaced)
  4. Hypertension NOT a risk factor in Goldman's original study - controversial
  5. Total = 53 points across 9 variables
  6. Class IV (≥26 points) = 56% cardiac mortality
  7. RCRI is the current preferred index - simpler (6 equal-weight variables), better validated in modern surgical populations
  8. The Goldman index established the principle that preoperative optimization of CCF (the highest-weighted factor) reduces perioperative risk - a principle that remains valid today
  9. The index is not designed for cardiac surgery patients - applies only to non-cardiac operations
  10. Goldman's study also showed that elective surgery in the context of recent MI should be deferred whenever possible

Quick Comparison Table

FeatureGoldman (1977)RCRI / Lee (1999)
Variables9 (unequal weights)6 (equal, 1 point each)
Max points536
ClassesI-IV0-3+
CCF markerS3/JVPHistory of CHF
DiabetesNot includedInsulin-dependent DM
Cerebrovascular diseaseNot includedIncluded
Renal diseaseIncluded (general status)Creatinine >2 mg/dL
Current useLargely historicalPreferred current tool

Sources: Goldman L et al., NEJM 1977; Miller's Anesthesia 10e; Barash's Clinical Anesthesia 9e; Fuster and Hurst's The Heart 15e; Morgan & Mikhail's Clinical Anesthesiology 7e

The anaesthetic management of strangulated inguinal hernia in 60 year old the patient with a recent myocardial infarction. For md Anaesthesia exam .

Your credits are exhausted. Your daily credits reset tomorrow, or you can purchase a top-up for more.

What are the common problems encountered during Anaesthesia for geriatric patients . 2. Write down the pathological changes in respiratory system occurring in old age and its implications to anaesthesia practice. For md Anaesthesia exam

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, authoritative content from all three major anesthesia textbooks. Let me compile the full exam answer.

Part 1: Common Problems Encountered During Anaesthesia for Geriatric Patients

Introduction

Geriatric patients (typically defined as age ≥65 years) present unique challenges to the anaesthesiologist. They are not simply "old adults" - they represent a physiologically distinct population with multiple co-morbidities, altered pharmacology, reduced physiological reserve, and limited ability to compensate for surgical stress. Age itself is not a contraindication to anaesthesia, but perioperative morbidity and mortality are significantly higher than in younger patients.
The key principle: physiological age matters more than chronological age. Wide individual variation exists, and the concept of frailty (decreased physiological reserve across multiple systems) is now more predictive of outcome than age alone.

A. Cardiovascular Problems

Physiological Changes

  • Decreased arterial elasticity (medial fibrosis) → increased afterload → left ventricular hypertrophy → diastolic dysfunction
  • Elevated systolic blood pressure with widened pulse pressure (once pulse pressure ≥80 mmHg, associated with increased all-cause mortality)
  • Resting systolic function is preserved even in octogenarians in the absence of disease - but diastolic filling is impaired
  • Decreased adrenergic receptor sensitivity and decreased β-receptor responsiveness
  • Decreased maximal heart rate (declines ~1 beat/min/year after age 50) - limits chronotropic response to stress
  • Decreased baroreceptor reflex → poor compensation for hypotension
  • Fibrosis of conduction system and loss of sinoatrial node cells → increased incidence of arrhythmias (AF, sick sinus syndrome, heart block)
  • Ischemic preconditioning is diminished or absent from ~age 65 onwards

Common Pathology in Geriatric Population

  • Atherosclerosis, coronary artery disease, essential hypertension
  • Congestive heart failure (especially diastolic), aortic stenosis, atrial fibrillation

Anaesthetic Implications

  • Haemodynamic instability during induction - very sensitive to preload reduction (diastolic dysfunction requires adequate filling)
  • Hypotension with induction agents (reduced dose required; use etomidate if cardiac reserve poor)
  • Blunted tachycardic response to hypotension - bradycardia may be the predominant response to hypovolaemia
  • High prevalence of undiagnosed or underdiagnosed cardiac disease
  • Systolic murmurs in elderly must raise suspicion of aortic stenosis
  • Continue beta-blockers and statins perioperatively
  • Invasive arterial monitoring for major procedures

B. Respiratory Problems

(Covered in detail in Part 2 below)

C. Renal Problems

Physiological Changes

  • Decreased renal blood flow and renal plasma flow (~1% per year after age 40)
  • Decreased glomerular filtration rate (GFR declines ~10 mL/min per decade from age 40)
  • Decreased renal mass (25-30% reduction by age 80)
  • Impaired tubular function → impaired sodium handling, impaired concentrating and diluting ability
  • Serum creatinine may be normal despite reduced GFR because lean muscle mass (creatinine source) also decreases - creatinine is therefore an unreliable marker; use eGFR

Anaesthetic Implications

  • Predisposed to both dehydration AND fluid overload (narrow therapeutic window for fluid management)
  • Prolonged drug elimination (renally excreted drugs: morphine-6-glucuronide, pancuronium, neostigmine, digoxin)
  • Avoid NSAIDs (nephrotoxic), aminoglycosides, high-contrast loads
  • Careful fluid management: avoid under- and over-hydration
  • Electrolyte imbalances (hyponatraemia, hyperkalaemia) more common

D. Central Nervous System (CNS) Problems

Physiological Changes

  • Brain mass decreases (~10% by age 80); cerebral blood flow decreases
  • Loss of neurons, reduction in neurotransmitters (dopamine, acetylcholine, serotonin)
  • Decreased cerebrovascular autoregulation range
  • Reduced MAC (minimum alveolar concentration) - declines ~6% per decade after age 40; a 80-year-old may require only 50-60% the MAC of a young adult

Key Anaesthetic Problems

1. Postoperative Delirium (POD)

  • Incidence: 15-50% in elderly surgical patients; higher after orthopaedic and cardiac surgery
  • Characterised by acute fluctuating confusion, disorientation, agitation or hypoactivity
  • Risk factors: pre-existing cognitive impairment, anticholinergic drugs, meperidine, benzodiazepines, sleep deprivation, pain, immobility, urinary catheters
  • AGS guidelines: Avoid meperidine, anticholinergics, and benzodiazepines; employ non-opioid analgesia where possible

2. Postoperative Cognitive Dysfunction (POCD) / Perioperative Neurocognitive Disorder (PND)

  • Detectable in 10-15% of patients >60 years old at 3 months after major surgery
  • Short-term memory most affected
  • Multifactorial: drug effects, pain, hypothermia, metabolic disturbance, inflammatory response, emboli
  • Animal studies suggest anaesthesia alone (without surgery) can impair learning for weeks
  • Greater risk in inpatients vs outpatients; higher after cardiac and major orthopaedic procedures

3. Increased Sensitivity to CNS Drugs

  • Lower dose requirements for propofol, etomidate, opioids, benzodiazepines, and barbiturates
  • Particularly sensitive to centrally acting anticholinergics (scopolamine, atropine)
  • Slower emergence and recovery from general anaesthesia

E. Thermoregulatory Problems

  • Elderly patients are highly prone to hypothermia perioperatively
  • Impaired vasoconstriction response to cold
  • Decreased heat production (lower basal metabolic rate)
  • Anaesthetic agents (inhalational, propofol, alfentanil) lower the threshold for vasoconstriction/shivering by ~4°C; ageing adds an additional ~1°C impairment
  • Consequences of hypothermia: myocardial ischaemia, coagulopathy, wound infection, prolonged drug metabolism, delayed emergence
  • Shivering (if it occurs) places severe metabolic stress on borderline cardiac/pulmonary reserve
  • Management: active warming devices (forced-air blankets), warm IV fluids, temperature monitoring throughout

F. Pharmacological Problems

Pharmacokinetic Changes

  • Decreased total body water (↓ lean mass) → increased plasma concentration of water-soluble drugs
  • Increased body fat → increased volume of distribution and prolonged effect of lipid-soluble drugs
  • Reduced plasma albumin → more free (active) drug for albumin-bound drugs (barbiturates, benzodiazepines, opioids)
  • α1-acid glycoprotein may be elevated (acute-phase reactant) → reduced free fraction of basic drugs (local anaesthetics)
  • Reduced liver mass and hepatic blood flow → prolonged hepatic drug metabolism (Phase I reactions more affected than Phase II)
  • Reduced renal clearance (as above) → prolonged elimination

Pharmacodynamic Changes

  • Reduced MAC for volatile agents
  • Increased brain sensitivity to CNS depressants
  • Decreased β-adrenergic responsiveness → reduced response to beta agonists and antagonists
  • Neuromuscular junction changes: morphological changes occur (NMJ lengthens, synaptic folds degenerate, Schwann cell invasion) but overall margin of safety is maintained; some NMBAs (vecuronium) have prolonged effect due to pharmacokinetic rather than pharmacodynamic changes; no evidence of succinylcholine-induced hyperkalaemia from NMJ changes alone

Practical Implications

  • Reduce induction doses of propofol by 30-50%
  • Titrate opioids carefully; start low
  • Use short-acting agents where possible (mivacurium, atracurium, rocuronium with sugammadex reversal)
  • Avoid pancuronium (tachycardia, prolonged block)
  • Regional anaesthesia is often preferable to reduce CNS drug burden

G. Musculoskeletal and Airway Problems

  • Sarcopenia - progressive loss of lean body mass and muscle strength
  • Osteoporosis - risk of fracture from positioning; careful padding essential
  • Arthritis - may limit neck extension, restrict mouth opening → difficult airway anticipated
  • Degenerative cervical spine disease - limits neck extension and atlantoaxial mobility → risk of cord injury during intubation
  • Skin atrophy - fragile skin susceptible to injury from adhesive tape, electrocautery pads, ECG electrodes
  • Fragile veins - difficult IV access; easily ruptured by cannulae

H. Other Common Problems

  • Multiple comorbidities and polypharmacy (drug interactions, withdrawal effects)
  • Malnutrition and hypoalbuminaemia - impairs wound healing, alters drug binding
  • Frailty (assessed by Fried criteria: shrinkage, weakness, exhaustion, low physical activity, slowness; 4-5 = frail) - independent predictor of poor surgical outcome
  • Pre-existing cognitive impairment/dementia - impacts consent, postoperative recovery
  • Impaired hepatic function → reduced drug metabolism, reduced coagulation factor synthesis
  • Aspiration risk - impaired swallowing and laryngeal reflexes, reduced lower oesophageal tone, gastroparesis in diabetics
  • Ethical issues - living wills, healthcare proxies, end-of-life discussions; one-third of elderly Medicare patients undergo surgery in their last year of life


Part 2: Pathological Changes in the Respiratory System in Old Age and Implications for Anaesthesia

Overview

The respiratory system undergoes significant structural and functional changes with ageing. These changes, even without superimposed disease, substantially reduce pulmonary reserve and increase the risk of perioperative respiratory complications.

A. Structural Changes in the Lung Parenchyma

1. Loss of Elastin (Decreased Lung Tissue Stiffness / Increased Lung Compliance)

  • With ageing, elastin fibres are progressively lost from lung parenchyma. Unlike other tissues in the body, this elastin is not replaced by collagen - so the lung actually becomes easier to inflate (increased pulmonary compliance)
  • This is fundamentally different from emphysema, where there is actual alveolar wall destruction, but the functional consequences are similar

2. Alveolar Changes

  • Decreased alveolar surface area (alveolar enlargement, reduced alveolar wall count) - not destruction but reduction in total surface available for gas exchange
  • Reduces diffusing capacity (DLCO declines with age)
  • Contributes to an age-related decline in resting PaO₂

Anaesthetic Implication

  • Reduced reserve for gas exchange - poorly tolerated periods of apnoea, atelectasis, or hypoventilation
  • Even brief periods of desaturation during induction can be dangerous

B. Airway Changes - The Closing Capacity Problem

The Central Mechanism: Loss of Small Airway Tethering

  • Small airways (<2 mm diameter) have no cartilaginous support; they remain open because of the outward tethering pull exerted by surrounding elastic lung tissue
  • As lung elastin is lost, this tethering pull diminishes
  • Small airways tend to close at a higher lung volume than before - this is reflected as an increase in Closing Capacity (CC)

Critical Relationship: CC vs FRC

Age GroupPositionRelationship
Young adultAnyFRC > CC (airways remain open throughout tidal breathing)
~45 yearsSupineCC = FRC (critical crossover point in supine position)
~65 yearsSitting (erect)CC = FRC (crossover even sitting upright)
Older elderlyAnyCC > FRC → airways close during normal tidal breathing
When CC exceeds FRC: small airways close during tidal breathing → gas is trapped distal to the closed airways → V/Q mismatch → hypoxaemia.

Anaesthetic Implication - THE MOST IMPORTANT RESPIRATORY CHANGE

  • Induction of general anaesthesia further reduces FRC by 15-20% (supine position, loss of respiratory muscle tone, abdominal content pressure)
  • In elderly patients where CC already exceeds FRC, induction causes extensive small airway closureatelectasis, intrapulmonary shunt, hypoxaemia
  • This is why elderly patients desaturate rapidly during induction and why PEEP is important during mechanical ventilation
  • Pre-oxygenation before induction is absolutely mandatory and should be thorough (3-5 minutes of 100% O₂)

C. Lung Volume Changes with Ageing

ParameterChange with AgeMechanism
Total Lung Capacity (TLC)UnchangedLung compliance ↑ balanced by chest wall stiffness ↑
Vital Capacity (VC)Decreased↑ RV with near-unchanged TLC
Expiratory Reserve Volume (ERV)DecreasedAirways close earlier, trapping gas
Residual Volume (RV)Increased (5-10%/decade)Small airway closure traps gas
Functional Residual Capacity (FRC)Largely unchangedERV ↓ + RV ↑ = sum largely stable
Closing Capacity (CC)Increased significantlyLoss of elastic recoil, less tethering
FEV₁Decreased (~30 mL/year after age 30)Loss of elastic recoil
FEV₁/FVC ratioDecreasedObstructive pattern even without disease
Diffusing capacity (DLCO)DecreasedReduced alveolar surface area

D. Chest Wall and Respiratory Mechanics

1. Increased Chest Wall Stiffness / Barrel-Shaped Chest

  • Calcification of costal cartilages and increased rib stiffness → reduced chest wall compliance
  • The thorax becomes more barrel-shaped over time (kyphosis, loss of disc height increases AP diameter)
  • Barrel-shaped thorax → flattening of the diaphragm → mechanical disadvantage: less diaphragmatic curvature reduces its ability to generate negative intrapleural pressure

2. Respiratory Muscle Weakness

  • General sarcopenia affects respiratory muscles including the diaphragm and intercostals
  • Increased work of breathing (stiff chest wall + weakened muscles)
  • Decreased maximal breathing capacity
  • Elderly patients are prone to respiratory fatigue when minute ventilation must be increased (sepsis, pain, airway obstruction, postoperative state)

Anaesthetic Implication

  • Residual neuromuscular blockade is extremely dangerous in elderly patients - even small amounts of residual paralysis can precipitate respiratory failure
  • Use objective neuromuscular monitoring (train-of-four with TOF ratio >0.9 before extubation)
  • Weaning from ventilation may be prolonged
  • Postoperative respiratory failure risk is high especially after thoracic and upper abdominal surgery
  • Epidural analgesia can help by enabling deep breathing without pain

E. Ventilation-Perfusion (V/Q) Mismatch and Hypoxaemia

  • Loss of elastic tethering makes ventilation less uniform - poorly ventilated regions continue to receive blood flow → V/Q mismatch and intrapulmonary shunt
  • Reduced alveolar surface area
  • Resting PaO₂ declines with age:
    • Formula: PaO₂ = 100 - (age/3) (approximate, in mmHg, breathing room air)
    • Or: PaO₂ (mmHg) ≈ 109 - 0.43 × age
    • A healthy 70-year-old may normally have PaO₂ of ~76-80 mmHg

Anaesthetic Implication

  • Establish baseline ABG values preoperatively in elderly patients with significant respiratory disease
  • Do not be reassured by a "normal for age" PaO₂ - it represents diminished reserve
  • Supplemental oxygen in recovery is mandatory
  • SpO₂ targets should be set conservatively

F. Ventilatory Control - Blunted Central Responses

Decreased Chemoreceptor Sensitivity

  • ~50% decrease in the ventilatory response to hypercapnia with ageing
  • Even greater decrease in ventilatory response to hypoxia - especially at night (nocturnal hypoxic episodes common)
  • Generalized loss of muscle tone affects the hypopharyngeal and genioglossal muscles → predisposed to upper airway obstruction and obstructive sleep apnoea
  • ~75% of people over 65 years may have some form of sleep-disordered breathing

Anaesthetic Implications

  • Cannot rely on the normal hypercapnic or hypoxic drive to trigger spontaneous ventilation
  • Respiratory depression from opioids, sedatives, and residual anaesthetics is poorly tolerated
  • High risk of postoperative apnoea and hypoxia, especially in the first night postoperatively
  • Sleep-disordered breathing increases risk of postoperative desaturation enormously
  • CPAP may be needed postoperatively in at-risk patients
  • Opioid-sparing techniques (NSAIDs cautiously, regional anaesthesia, paracetamol, dexmedetomidine) help

G. Impaired Cough and Aspiration Risk

  • Decreased cough reflex - reduced velocity, less effective airway clearance
  • Impaired swallowing (reduced coordination of pharyngeal muscles, laryngeal elevation)
  • Aspiration is a significant cause of community-acquired and postoperative pneumonia in the elderly
  • Reduced mucociliary clearance

Anaesthetic Implications

  • Aspiration precautions for all elderly patients (treat as potentially at risk)
  • Avoid excessive sedation that further impairs airway protective reflexes
  • Consider RSI for any patient with reduced conscious level or known dysphagia
  • Careful extubation only when fully awake with intact reflexes
  • Postoperative physiotherapy and incentive spirometry

Summary Table: Respiratory Changes and Their Anaesthetic Implications

ChangeConsequenceAnaesthetic Implication
↓ Lung elastin (↑ lung compliance)↑ Closing Capacity (CC)CC > FRC → atelectasis on induction
CC > FRC (from ~age 65 sitting)Small airway closure during tidal breathingV/Q mismatch, ↓ PaO₂
↑ RV, ↓ ERV, ↑ FRC (minimal)Air trappingSlow wash-in/out of volatile agents
↓ FEV₁, ↓ FEV₁/FVCAirflow obstruction tendencyPlan for postop ventilation if marginal
↓ Alveolar surface area, ↓ DLCOImpaired gas exchangeRapid desaturation; thorough pre-oxygenation
Stiff chest wall + sarcopenia↑ Work of breathingHigh risk of respiratory failure and fatigue
Blunted response to CO₂ and hypoxiaCannot rely on hypercapnic driveOpioids/sedatives cause apnoea; monitor SpO₂ closely
Genioglossal muscle weaknessUpper airway obstructionHigh OSA prevalence; CPAP post-op
↓ Cough, ↓ swallowingAspiration, retained secretionsAspiration precautions; full reversal of NMB before extubation

Sources: Morgan & Mikhail's Clinical Anesthesiology 7e (Chapter 43: Geriatric Anaesthesia); Barash, Cullen & Stoelting's Clinical Anesthesia 9e (Chapter 34: Geriatrics); Miller's Anaesthesia 10e (Chapter 11, Chapter 27)
This is a shared conversation. Sign in to Orris to start your own chat.